Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Chou

Showing results (1211-1220 of 1,244) with videos related to

Pageof 125
Sort By:
Leukemia|April 9, 2016
Genetic alterations and their clinical implications in older patients with acute myeloid leukemiaC-H Tsai, H-A Hou, J-L Tang, et al.
Arzneimittel-Forschung|October 9, 1999
Effect of Sch 55700, a humanized monoclonal antibody to human interleukin-5, on eosinophilic responses and bronchial hyperreactivityR W Egan, D Athwal, M W Bodmer, et al.
Blood Cancer Journal|January 21, 2014
Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndromeT-C Chen, H-A Hou, W-C Chou, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2001
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivoJ M Strizki, S Xu, N E Wagner, et al.
Genes, Brain, and Behavior|August 22, 2009
Clustering by neurocognition for fine mapping of the schizophrenia susceptibility loci on chromosome 6pS-H Lin, C-M Liu, Y-L Liu, et al.
ESMO Open|July 7, 2026
Efficacy and safety of durvalumab plus gemcitabine-cisplatin in combined hepatocellular-cholangiocarcinoma versus cholangiocarcinomaC-C Hsu, K-Y Yeh, C-F Chang, et al.
Leukemia|August 10, 2013
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemiaH A Hou, C C Lin, W C Chou, et al.
ESMO Open|October 9, 2025
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancerD Tai, T Conroy, J J X Lee, et al.
Nature Communications|January 8, 2025
Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteersChristian J Maine, Shigeki J Miyake-Stoner, Darina S Spasova, et al.
Science (New York, N.Y.)|March 21, 2024
Stable quantum-correlated many-body states through engineered dissipationX Mi, A A Michailidis, S Shabani, et al.
Pageof 125

Showing results (1211-1220 of 1,244) with videos related to

Sort By:
Pageof 125
Leukemia|April 9, 2016
Genetic alterations and their clinical implications in older patients with acute myeloid leukemiaC-H Tsai, H-A Hou, J-L Tang, et al.
Arzneimittel-Forschung|October 9, 1999
Effect of Sch 55700, a humanized monoclonal antibody to human interleukin-5, on eosinophilic responses and bronchial hyperreactivityR W Egan, D Athwal, M W Bodmer, et al.
Blood Cancer Journal|January 21, 2014
Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndromeT-C Chen, H-A Hou, W-C Chou, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2001
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivoJ M Strizki, S Xu, N E Wagner, et al.
Genes, Brain, and Behavior|August 22, 2009
Clustering by neurocognition for fine mapping of the schizophrenia susceptibility loci on chromosome 6pS-H Lin, C-M Liu, Y-L Liu, et al.
ESMO Open|July 7, 2026
Efficacy and safety of durvalumab plus gemcitabine-cisplatin in combined hepatocellular-cholangiocarcinoma versus cholangiocarcinomaC-C Hsu, K-Y Yeh, C-F Chang, et al.
Leukemia|August 10, 2013
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemiaH A Hou, C C Lin, W C Chou, et al.
ESMO Open|October 9, 2025
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancerD Tai, T Conroy, J J X Lee, et al.
Nature Communications|January 8, 2025
Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteersChristian J Maine, Shigeki J Miyake-Stoner, Darina S Spasova, et al.
Science (New York, N.Y.)|March 21, 2024
Stable quantum-correlated many-body states through engineered dissipationX Mi, A A Michailidis, S Shabani, et al.
Pageof 125